XBiotech Inc
Closed
2.29 1.33
Overview
Share price change
24h
Min
2.26
Max
2.3
Income | 21M -5.5M |
|---|---|
EPS | -0.181 |
Employees | 87 |
EBITDA | 24M -5.1M |
Next Earnings | 11 sie 2026 |
|---|
Market Cap | -5.5M 70M |
|---|---|
Previous open | 0.96 |
Previous close | 2.29 |
XBiotech Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
XBiotech Inc Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.